Autolus Therapeutics: Detailed Company Information & Corporate Profile

Contact top employees from Autolus Therapeutics

Summary

Autolus Therapeutics is a public company that has been in the industry for 12 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by Christian Itin. Its headquarters is located at London, England, GB. The number of employees ranges from 250 to 500. The annual revenue of Autolus Therapeutics varies between 50M and 100M. Total funding of the company - $320.7M. To connect with Autolus Therapeutics employee register on SignalHire.

Autolus Therapeutics Websiteautolus.com
Social Links
linkedIn
Phone Number44-20-3829-6230
Industries
Autolus Therapeutics Headquarters addressAutolus Limited, London, W12 7RZ GB
Company Size500-1000 employees
SIC Code2836
Founded2014
Estimated Annual Revenue$50M - 100M
Operating StatusIndependent Company

Autolus Therapeutics Org Chart

Chief Executive Officer

Chief Executive Officer

phone_icon
email_icon

C-Level

Competitors

Name
Founded
Type
Employees
Revenue
Funding
1979Public
Company
250 - 500 182.3K $296.4M
2009Public
Company
1.0K - 5.0K 2B $634.9M
2008Privately
Held
25 - 100 2.2M $160.5M
2013Privately
Held
250 - 500 421.4M $377.8M

Workforce Turnover

Number of employees switched from or switched to

arrow
Total employee turnover

Departmental sample breakdown

arrow
Turnover activity captured in SignalHire's departmental sample ( employees):

Length of Employment

arrow

Autolus Therapeutics's workforce includes employees across a wide range of tenure levels.

1% have been with the company for less than 1 year21% have been with the company for 1 to 2 years32% have been with the company for 3 to 4 years22% have been with the company for 5 to 7 years21% have been with the company for 8 to 10 years4% have been with the company for more than 11 years

Former Employees: Role Changes

Role at Former Company
Role at New Company
Contact top employees from Autolus Therapeutics
Vikram Vemulapalli MD
Vikram Vemulapalli MDHead of Drug Safety and Pharmacovigilance ED
Email (5)
v****************i@pfizer.com , v****************i@legendbiotech.com , o********3@live.com , ...
Phone (1)
+1-***-***-9690
Unlock contacts
Todd Bittiger
Todd BittigerHead of Procurement - Commercial and Medical Affairs
Email (6)
t***********r@novartis.com , b******r@novartis.com , t***********r@tevapharm.com , ...
Phone (1)
+1-***-***-9239
Unlock contacts
Mike Sonnenberg
Mike SonnenbergVice President, Technology and Analytics
Email (6)
m****************g@fatetherapeutics.com , m*********g@kitepharma.com , m*************g@astrazeneca.com , ...
Phone (4)
+1-205-***-**83 , +1-909-***-**19 , ...
Unlock contacts
Chris Fong
Chris FongVice President of Cell Therapy and Supply Chain Operations
Email (5)
c********g@bms.com , c****g@autolus.com , c****f@amgen.com , ...
Phone (1)
+1-***-***-8925
Unlock contacts
Jonathan Willmer
Jonathan WillmerVice President Clinical Development (Autoimmune)
Phone (1)
+1-***-***-4814
Unlock contacts
Nirav Patel
Nirav PatelExecutive Director, Head of Regulatory Affairs Oncology
Email (5)
n*********l@sunovion.com , n*********l@agios.com , n*********l@sanofi.com , ...
Phone (1)
+1-***-***-3898
Unlock contacts
Danielle Graves
Danielle GravesVice President Compliance
Email (6)
d*************s@axiomlaw.com , d*****s@atarabio.com , d*****s@bmrn.com , ...
Phone (1)
+1-***-***-1901
Unlock contacts
Melia Loskill
Melia LoskillVice President of Market Access
Email (4)
k**********n@brandwatch.com , m******l@celgene.com , m***********l@novartis.com , ...
Phone (4)
+1-480-***-**50 , +1-205-***-**32 , ...
Unlock contacts
Emma Bin
Emma BinHR Director, US HR Head
Email (5)
y***1@rangtech.com , e***b@genscript.com , e******n@genscript.com , ...
Phone (2)
+1-205-***-**23 , +1-480-***-**82
Unlock contacts
Austin
AustinVice President, Patient & Channel Access
Email (2)
f***@yahoo.com , a***@zspharma.com
Phone (3)
+1-623-***-**01 , +1-909-***-**70 , ...
Unlock contacts
Diane Crombie Hogan
Diane Crombie HoganClinical Site Manager
Phone (1)
+1-***-***-7386
Unlock contacts
Mark Prygoda
Mark PrygodaSenior Director, US Market Access Strategy & Operations
Email (4)
p***@autolus.com , p***@yahoo.com , p***@kitepharma.com , ...
Phone (1)
+1-870-***-**30
Unlock contacts
Matthias Will
Matthias WillChief Development Officer (CDO)
Email (4)
m***l@cytomx.com , m***********l@gilead.com , m***********l@crisprtx.com , ...
Phone (1)
+1-***-***-2000
Unlock contacts
Leisha Thein
Leisha TheinSenior Executive Assistant
Phone (1)
+1-***-***-8143
Unlock contacts
Yi Rou Wang
Yi Rou WangAssociate Director, Statistical Pogrammimg
Email (2)
y****g@autolus.com , a*******e@gmail.com
Phone (1)
+1-***-***-1188
Unlock contacts
Courtney Roos
Courtney RoosDirector, US GAAP & SOX
Phone (1)
+1-***-***-4454
Unlock contacts

Autolus Therapeutics Corporate Information: FAQ

Autolus Therapeutics operates in the Biotech industries. More details can be found on the official website: autolus.com.
The headquarters of Autolus Therapeutics are located in London, United Kingdom.
The current CEO of Autolus Therapeutics is Christian Itin
You can contact Autolus Therapeutics by phone at 44-20-3829-6230.
Autolus Therapeutics currently employs 500-1000 people.
You can contact Autolus Therapeutics by phone at 44-20-3829-6230, by email at contact@autolus.com, through social media (LinkedIn), or via the contact form on autolus.com.
Autolus Therapeutics's revenue is approximately 51.1M.
Well-known competitors of Autolus Therapeutics include INOVIO Pharmaceuticals, Inc., Kite Pharma, Immune Design and Spark Therapeutics, Inc..

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP